There is no single life expectancy for people who use methamphetamine, but the data paints a stark picture. A study of methamphetamine-related deaths in San Francisco found an average age at death of 36.8 years, with only 11% of cases surviving past 50. The three leading killers are overdose, cardiovascular disease, and suicide, and each of these risks climbs sharply with continued use.
Average Age at Death
Research on methamphetamine-related fatalities shows most deaths occur decades earlier than the general population would expect. A forensic study tracking cases from 2000 to 2019 found the mean age at death rose from 32.6 years to 42.2 years over that period. That increase likely reflects shifting demographics (an aging population of users) rather than improved survival. Male users who died averaged 42.5 years old by 2019; female users averaged 41.2.
These numbers don’t mean every person who uses meth dies in their 30s or 40s. They represent people whose deaths were directly linked to the drug. But they illustrate how dramatically long-term meth use shortens life. The average American lives to about 77. Dying at 42 means losing roughly 35 years.
Overdose Is the Leading Cause of Death
Between January 2021 and June 2024, methamphetamine was involved in 31.2% of all drug overdose deaths in the United States. That’s nearly one in three overdose fatalities. The numbers have been climbing for years, driven in large part by the mixing of meth with opioids like fentanyl.
This combination is especially deadly. Among methamphetamine-involved overdose deaths, 68.8% also involved opioids. A person may not even know their meth contains fentanyl. Only about 14.5% of stimulant overdose deaths involved stimulants alone, meaning the vast majority of fatal overdoses happen when meth is used alongside other drugs.
Heart Disease as a Silent Killer
After overdose and accidents, cardiovascular disease is the leading cause of death in methamphetamine users. Meth forces the heart to work harder by flooding the body with stress hormones, constricting blood vessels, and raising blood pressure. Over time, this causes the heart muscle to weaken and enlarge, a condition called methamphetamine-associated cardiomyopathy.
The damage goes beyond the heart muscle itself. Meth accelerates the buildup of plaque inside arteries, increases inflammation in blood vessel walls, and disrupts the electrical signals that keep the heart beating in rhythm. A large analysis of over 35 million hospital patients found that methamphetamine users had a 27% higher risk of sudden cardiac death compared to non-users. Among people who died from stimulant overdoses without opioids involved, nearly 39% had a known history of cardiovascular disease, roughly four times the rate in the general adult population.
The structural scarring (fibrosis) that meth causes in heart tissue is the key factor in whether recovery is possible. If someone stops using meth before too much scarring develops, heart function can improve. But in patients who continued using, cardiac function did not improve at all.
Damage to the Brain, Kidneys, and Liver
Meth doesn’t just target the heart. It causes widespread organ damage that accumulates over years of use.
In the brain, meth destroys the circuits that produce and regulate dopamine and serotonin, two chemicals essential for mood, motivation, and cognitive function. It triggers chronic inflammation, kills neurons through oxidative stress, and impairs the brain’s ability to form new memories and learn. Because meth is cleared from the brain slowly, each use extends the window of toxic exposure.
The kidneys are vulnerable because meth can cause muscle tissue to break down rapidly, a condition called rhabdomyolysis. When muscle proteins flood the bloodstream, they deposit in the kidneys and trigger a chain reaction of damage: iron from these proteins generates destructive molecules that constrict blood vessels in the kidneys and choke off blood flow. This can lead to acute kidney failure after a single heavy use episode, or chronic kidney disease after repeated exposure.
The liver faces similar oxidative stress. Acute liver failure is a recognized complication of meth use, alongside damage to the eyes (including vision loss), blood vessels throughout the body, and the barrier that normally protects the brain from toxins in the bloodstream.
Suicide and Violent Death
Methamphetamine significantly increases the risk of death by suicide. The drug causes paranoia, psychosis, severe depression during withdrawal, and impulsive decision-making. In one case-control study of meth-related deaths, 21% of cases involved suicide. Hanging was the most common method (71.4% of suicides), followed by self-poisoning (17.9%) and other violent means including firearms and jumping from heights.
The risk isn’t limited to the acute high. The crash that follows a meth binge can produce intense despair and hopelessness, and the long-term depletion of dopamine leaves chronic users with a diminished capacity to feel pleasure or motivation. These psychological effects persist for months after the last use, keeping the suicide risk elevated well into early recovery.
How Recovery Changes the Outlook
Quitting meth does reduce the risk of premature death, and the benefit grows with each year of sobriety. A long-term study published in the American Journal of Public Health found that for every additional year of continuous abstinence, the odds of dying dropped by 19%. Even periods of sobriety that weren’t continuous helped: for every 10-percentage-point increase in time spent abstinent, the odds of death fell by 26%.
Treatment itself had a protective effect. Each additional episode of substance abuse treatment reduced the odds of mortality by 32%. The benefit came partly from the treatment itself and partly from the abstinence it supported.
Some damage is reversible, some is not. Heart function can recover if the scarring hasn’t progressed too far. Brain dopamine systems partially rebuild over 12 to 18 months of sobriety, though some cognitive deficits may linger. Kidney and liver damage depends on severity. The critical variable is stopping before organ damage becomes permanent, which makes early intervention far more effective than late-stage treatment.
Certain factors predicted higher mortality risk regardless of treatment: being older at the time of entering treatment, having a preexisting chronic illness, and spending more time engaged in illegal activity (a proxy for ongoing high-risk environments). These findings suggest that the sooner someone enters recovery and the more stable their living situation, the better their chances of surviving long term.